Macular telangiectasia type 2 (mactel)

Clinical trials for Macular telangiectasia type 2 (mactel) explained in plain language.

Never miss a new study

Get alerted when new Macular telangiectasia type 2 (mactel) trials appear

Sign up with your email to follow new studies for Macular telangiectasia type 2 (mactel), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

Eye implant for rare vision loss gets Long-Term safety review

Disease control Recruiting now

This study looks at the long-term safety of an eye implant (NT-501) for people with MacTel type 2, a rare disease that damages the center of the retina. About 285 adults who already received the implant in earlier studies will be followed, and some who had a sham procedure can no…

Matched conditions: MACULAR TELANGIECTASIA TYPE 2 (MACTEL)

Phase 4 • Sponsor: Neurotech Pharmaceuticals • Aim: Disease control

Last updated Aug 15, 2026 00:00 UTC

Macular telangiectasia type 2 (mactel)

Get alerted when new Macular telangiectasia type 2 (mactel) trials appear

Eye implant for rare vision loss gets Long-Term safety review